Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Florian Schönharting | M | 55 |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | 23 years |
| Henrik Ehlers Wulff | M | 54 | 25 years | |
| Karsten Munk Knudsen | M | 53 | 25 years | |
| Camilla Sylvest | F | 52 | 28 years | |
| Maziar Mike Doustdar | M | 54 | 32 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jan Mikkelsen | M | 65 |
Profound Pharma AS
 Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million.
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 14 years |
| Jakob Riis | M | 58 | 21 years | |
| Anders Pedersen | M | 64 |
Profound Pharma AS
Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million. | - |
| Søren Thuesen Pedersen | M | 59 |
Technical University of Denmark
| 29 years |
| Grethe Nørskov Rasmussen | M | 62 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.
Technical University of Denmark
| 16 years |
| Carsten Hellmann | M | 60 | - | |
| Sigurd Okkels | M | - |
Profound Pharma AS
Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million. | 6 years |
| Harry Penner | M | 78 | 8 years | |
| Jesper Brandgaard | M | 60 | 20 years | |
| George Li | M | - |
University of Strasbourg
| 3 years |
| Erik Michael Degn | M | - | 16 years | |
| Charlotte Dyring | M | 56 |
Technical University of Denmark
| 4 years |
| Henrik Juuel | M | 59 | - | |
| Lars Green | M | 57 | 27 years | |
| Frédéric Salomon | M | - |
University of Strasbourg
| 3 years |
| Christopher Yallop | M | - | 6 years | |
| Francis Ebel | M | 60 |
University of Strasbourg
| 2 years |
| Patrick Loustau | M | 61 | 14 years | |
| Henrik Poulsen | M | 57 | 1 years | |
| Kristian Slaarup Kongstad | M | 60 |
Technical University of Denmark
| 4 years |
| Eva Berneke | F | 55 |
Technical University of Denmark
| 4 years |
| Thomas Kähler | M | 53 |
Technical University of Denmark
| 4 years |
| Vincent Jean Jegou | M | 53 |
University of Strasbourg
| 4 years |
| Annette Stube | F | 57 | 11 years | |
| René Djurup | M | - | 4 years | |
| Hans Schambye | M | 59 |
Profound Pharma AS
Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million. | 1 years |
| Gitte L. Pedersen | F | 61 | 10 years | |
| Thomas Lethenborg | M | 55 |
Technical University of Denmark
| 5 years |
| Ruchita Sinha | F | - |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 4 years |
| Jean von Pfetten | M | 56 |
University of Strasbourg
| 2 years |
| Joan Schmidt | F | 60 | 20 years | |
| Tina Sejersgård Fanø | F | 55 |
Technical University of Denmark
| 4 years |
| Morten Holm Pedersen | M | - |
Technical University of Denmark
| 4 years |
| Zaiton binti Jamaluddin | F | 65 | 8 years | |
| Alexey Konov | M | - |
University of Strasbourg
| 3 years |
| Henrik Dalsgard | M | - |
Technical University of Denmark
| 3 years |
| Humberto Andrés Fuenzalida Etcheverry | M | 60 |
University of Strasbourg
| 3 years |
| Anna Héléne Barnekow | F | 60 | 2 years | |
| Liselotte Hyveled | F | 58 | 26 years | |
| Christian Poulsen | M | 58 |
Technical University of Denmark
| 4 years |
| Sean X. Du | M | - |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 8 years |
| Jan Behrendt Ibsoe | M | - |
Technical University of Denmark
| 1 years |
| Peter Trier Schleidt | M | 60 |
Technical University of Denmark
| 1 years |
| Martin Olin | M | 55 | 4 years | |
| Bo Pedersen | M | - |
Technical University of Denmark
| 3 years |
| Nathan Lassota | M | - |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | 1 years |
| John M. Barberich | M | 66 |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | 8 years |
| Villoo Morawala Zareer Patell | M | - |
University of Strasbourg
| 3 years |
| Henrik Nilsson | M | - |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | - |
| Torben Nissen | M | 53 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | - |
| Jack Nielsen | M | 60 |
Technical University of Denmark
| 1 years |
| Michael Brudevold Hansen | M | 55 |
Technical University of Denmark
| 4 years |
| Henrik Schimmell | M | 62 |
Technical University of Denmark
| 3 years |
| Christian Gröndahl | M | 60 | 14 years | |
| Steve Wang | M | - |
Technical University of Denmark
| 3 years |
| Claus Tycho Bræstrup | M | 79 | 10 years | |
| Finn M. Ulrich | M | - | 8 years | |
| Jan Öhrström | M | 67 | 9 years | |
| Bruce Carter | M | 80 | 4 years | |
| Henrik Pallisgaard Jensen | M | - |
Technical University of Denmark
| 1 years |
| Lawrence W. Briscoe | M | 79 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 9 years |
| Jan Ulf Sigvar J. Johansson | M | 79 | 7 years | |
| Peter David Suzdak | M | 65 | 7 years | |
| Anker Gunvald Lundemose | M | 63 | 4 years | |
| Valeta A. Gregg | M | 72 | 5 years | |
| Jens Jesper Ovesen | M | 67 | 4 years | |
| Per Toft Valstorp | M | 75 | 14 years | |
| Gudmund Knudsen | M | - |
Technical University of Denmark
| 1 years |
| Sergey Selifonov | M | - |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 4 years |
| Peter Nordkild | M | 69 | 2 years | |
| Howard Allan Simon | M | 65 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 2 years |
| Jennifer Glennon | F | - |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | 3 years |
| Hervé Besaucèle | M | - |
University of Strasbourg
| 3 years |
| Paul Quinlan | M | 61 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | 5 years |
| Hanne Damgaard Jensen | F | - | 4 years | |
| Allan Rasmussen | M | 57 |
Technical University of Denmark
| 4 years |
| Gorm Heron | M | - |
Technical University of Denmark
| 1 years |
| Thomas Feldthus | M | 64 | 3 years | |
| Peter Ruhdal Jensen | M | - |
Technical University of Denmark
| 3 years |
| Jette Traulsen | M | - | 5 years | |
| Stig Strøbæk | M | 60 | 30 years | |
| Henrik Enegaard Skaanderup | M | 61 |
Technical University of Denmark
| 1 years |
| Peder Holk Nielsen | M | 67 | 5 years | |
| Montserrat Andrade Detrell | M | - |
University of Strasbourg
| 1 years |
| Niels Fog | M | 64 |
Technical University of Denmark
| 1 years |
| Wyle Solomon | M | - |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | 5 years |
| Vincent Ricchiuti | M | - |
University of Strasbourg
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Denmark | 71 | 77.17% |
| France | 11 | 11.96% |
| United States | 9 | 9.78% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christian Hansen
- Personal Network
